Emerging Infectious Disease ISSN: 1080-6059

In Vitro Cell Culture Infectivity Assay for Human Noroviruses

Timothy M. Straub*

, Kerstin Höner zu Bentrup†, Patricia Orosz Coghlan‡, Alice Dohnalkova*, Brooke K. Mayer*¹, Rachel A. Bartholomew*, Catherine O. Valdez*, Cynthia J. Bruckner-Lea*, Charles P. Gerba‡, Morteza A. Abbaszadegan§, and Cheryl A. Nickerson†¹

Author affiliations: *Pacific Northwest National Laboratory, Richland, Washington, USA; †Tulane University School of Medicine, New Orleans, Louisiana, USA; ‡University of Arizona, Tucson, Arizona, USA; §Arizona State University, Tempe, Arizona, USA;

Main Article

Figure 2

Demonstration of cytopathic effect in infected tissue aggregates during the second infection trial. A) Uninfected aggregate, 24 h into the experiment. B) Cells infected with lysate from the first infection trial (P1) at 24 h postinfection. C) Stool sample flag2 at 24 s postinfection (P0). D) Stool sample 149 at 48 h postinfection (P0). Arrows indicate cells exhibiting unusual pathology.

Figure 2. Demonstration of cytopathic effect in infected tissue aggregates during the second infection trial. A) Uninfected aggregate, 24 h into the experiment. B) Cells infected with lysate from the first infection trial (P1) at 24 h postinfection. C) Stool sample flag2 at 24 s postinfection (P0). D) Stool sample 149 at 48 h postinfection (P0). Arrows indicate cells exhibiting unusual pathology.

Main Article

¹Current affiliation: Arizona State University, Tempe, Arizona, USA

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.